ScoreWhy is Nanjing Vishee Medical Technology Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 4.49% and Operating profit at -3.70% over the last 5 years
2
The company declared positive results in Mar'25 after negative results in Dec'24
- OPERATING CASH FLOW(Y) Highest at CNY 173.78 MM
- RAW MATERIAL COST(Y) Fallen by 1.13% (YoY)
- NET PROFIT(9M) Higher at CNY 102.15 MM
3
With ROE of 7.38%, it has a fair valuation with a 2.86 Price to Book Value
- Over the past year, while the stock has generated a return of 64.68%, its profits have risen by 3% ; the PEG ratio of the company is 13
- At the current price, the company has a high dividend yield of 0.4
4
Market Beating Performance
- The stock has generated a return of 64.68% in the last 1 year, much higher than market (China Shanghai Composite) returns of 22.49%
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Nanjing Vishee Medical Technology Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Nanjing Vishee Medical Technology Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Nanjing Vishee Medical Technology Co., Ltd.
27.25%
1.52
61.21%
China Shanghai Composite
23.91%
1.58
14.20%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
3.42%
EBIT Growth (5y)
-4.37%
EBIT to Interest (avg)
92.07
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.62
Sales to Capital Employed (avg)
0.26
Tax Ratio
11.10%
Dividend Payout Ratio
75.00%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
65.26%
ROE (avg)
8.58%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
8
Industry P/E
Price to Book Value
0.70
EV to EBIT
2.57
EV to EBITDA
2.17
EV to Capital Employed
0.36
EV to Sales
0.63
PEG Ratio
0.17
Dividend Yield
1.61%
ROCE (Latest)
14.10%
ROE (Latest)
9.24%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend24What is working for the Company
OPERATING CASH FLOW(Y)
Highest at CNY 182.19 MM
NET SALES(HY)
At CNY 243.24 MM has Grown at 20.02%
ROCE(HY)
Highest at 9.74%
INTEREST COVERAGE RATIO(Q)
The company hardly has any interest cost
RAW MATERIAL COST(Y)
Fallen by -5.33% (YoY
INVENTORY TURNOVER RATIO(HY)
Highest at 4.72 times
DEBTORS TURNOVER RATIO(HY)
Highest at 16.22 times
PRE-TAX PROFIT(Q)
Highest at CNY 70.37 MM
NET PROFIT(Q)
Highest at CNY 61.57 MM
EPS(Q)
Highest at CNY 0.65
-4What is not working for the Company
DEBT-EQUITY RATIO
(HY)
Highest at -53.03 %
CASH AND EQV(HY)
Lowest at CNY 1,954.26 MM
OPERATING PROFIT(Q)
Lowest at CNY 30.48 MM
Here's what is working for Nanjing Vishee Medical Technology Co., Ltd.
Operating Cash Flow
Highest at CNY 182.19 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CNY MM)
Net Sales
At CNY 243.24 MM has Grown at 20.02%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (CNY MM)
Pre-Tax Profit
Highest at CNY 70.37 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (CNY MM)
Pre-Tax Profit
At CNY 70.37 MM has Grown at 89.94%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (CNY MM)
Net Profit
Highest at CNY 61.57 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (CNY MM)
Net Profit
At CNY 61.57 MM has Grown at 85.35%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is positive
Net Profit (CNY MM)
EPS
Highest at CNY 0.65
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (CNY)
Inventory Turnover Ratio
Highest at 4.72 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Debtors Turnover Ratio
Highest at 16.22 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Raw Material Cost
Fallen by -5.33% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Nanjing Vishee Medical Technology Co., Ltd.
Debt-Equity Ratio
Highest at -53.03 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Operating Profit
Lowest at CNY 30.48 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (CNY MM)
Cash and Eqv
Lowest at CNY 1,954.26 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Non Operating Income
Highest at CNY 0.57 MM
in the last five periodsMOJO Watch
Increased income from non business activities may not be sustainable
Non Operating income
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
